臨牀消化器内科 Vol.26 No.4(2-3)


特集名 転移性肝癌 -- 多様化する治療
題名 大腸癌肝転移の治療 (3) 大腸癌肝転移に対する術前肝動注を用いた集学的治療
発刊年月 2011年 04月
著者 中居 卓也 近畿大学医学部外科
著者 奥野 清隆 近畿大学医学部外科
【 要旨 】 切除不能大腸癌肝転移に,ペグインターフェロンアルファ-2a (PEG-IFNα-2a)とフルオロウラシル(5-FU)を用いた肝動注免疫化学療法を行い,転移腫瘍の縮小とともに切除可能となれば肝切除を実施した.肝動注17例の有害事象は全例で投与当日の発熱を認めたが,休薬を要したものは白血球減少1例のみであった.腫瘍縮小効果はPR11例で奏効率は64.7%,肝切除は全身化学療法歴のある2例を含め8例(47.1%)に行い,術後合併症も軽微であった.自験例の術前全身化学療法と比較しても肝動注の副作用は少なく,化学療法歴があっても奏効が認められ切除前化学療法として有効的手段の一つである.
Theme Diversified Modalities of Liver Metastasis Treatment
Title Multidisciplinary Therapy with Preoperative Hepatic Arterial Infusion for Liver Metastases from Colorectal Cancer
Author Takuya Nakai Department of Surgery, Kinki University School of Medicine
Author Kiyotaka Okuno Department of Surgery, Kinki University School of Medicine
[ Summary ] After hepatic arterial immunochemotherapy with 5-fluorouracil (5-FU) and polyethylene glycol-interferon alpha-2a (PEG-IFNα-2a) was performed for treatment of unresectable liver metastasis from colorectal cancer, hepatic resection was performed following tumor shrinkage. Fever was observed as an adverse effect of hepatic arterial chemotherapy in all 17 patients on the day of administration. However, drug cessation was required in only one patient, who developed leucopenia. PR was observed in 11 patients, yielding a response rate of 64.7 %. Liver resection was safely performed on eight patients (47.1 %) including two with histories of chemotherapy. The side effects due to preoperative systemic chemotherapy observed in our patients, were greater than those due to hepatic arterial chemotherapy. In addition, this treatment is effective even for patients who have received chemotherapy. This modality should therefore become an accepted method of providing preoperative chemotherapy.
戻る